Föreläsningar och seminarier 2021 George Klein lecture: Targeting Cancer Metabolism: MYC, Clock, and Barriers

2021-12-13 15:00 Add to iCal
Campus Solna Zoom meeting (see link below)

The George and Eva Klein foundation (GEKS) presents a 2021 George Klein lecture

Speaker: Chi Van Dang, MD, PhD
Professor at the Wistar Institute, Philadelphia Scientific Director of Ludwig Institute for Cancer Research

Hosts: Georg and Eva Klein Foundation and Marie Arsenian Henriksson

Zoom details

Time and date: Dec 13, 2021 03:00 PM Stockholm

Zoom link: https://ki-se.zoom.us/j/64438405321?pwd=WjNpMmFKZ3prT2VpdmFyeEFBZU1vZz09

Meeting ID: 644 3840 5321
Passcode: 027463

Or dial +46 8 5050 0829 Sweden, +46 8 5052 0017 Sweden



Chi van Dang  is known for his work on the molecular signaling pathways and mechanisms that govern the unusual metabolism of cancer cells, which require vast quantities of energy and molecular building blocks to sustain proliferation.

He  was the first to show that the master regulator of gene expression MYC alters the utilization of a key sugar in cancer cells. Cancer cells can become addicted to their reengineered metabolic signaling and  disruption of  these pathways could be a powerful approach to treating cancer. He currently leads a Ludwig laboratory housed at The Wistar Institute in Philadelphia.

He started his  career in medicine and research at Johns Hopkins, where he was Director of the Division of Hematology and later the Johns Hopkins Family Professor in Oncology Research, the Vice Dean for Research and Director of the Hopkins Institute for Cell Engineering.

Subsequently he served as Director of the Abramson Cancer Center at the University of Pennsylvania Perleman School of Medicine, where he aunched a series of Translational Centers of Excellence to develop novel interventions for various cancers. He has authored over 250 scientific and medical articles, book chapters and two books.

He is a member of the National Academy of Medicine and chair the National Cancer Institute’s Board of Scientific Advisors.